CI
AGN

CX Institutional’s Allergan plc AGN Stock Holding History

CX Institutional’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,399
Closed -$425K – 880
2020
Q1 		$425K Buy
2,399
+49
+2% +$9.23K 0.07% 187
2019
Q4 		$449K Hold
2,350
– – 0.08% 157
2019
Q3 		$395K Buy
2,350
+37
+2% +$6.03K 0.06% 175
2019
Q2 		$387K Sell
2,313
-18
-0.8% -$2.49K 0.06% 174
2019
Q1 		$341K Buy
2,331
+64
+3% +$9.28K 0.06% 172
2018
Q4 		$303K Buy
+2,267
New +$372K 0.06% 148

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

CX Institutional's AGN Position: Q2 2020 in Review

CX Institutional sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,399 shares — an estimated $425K sold.

CX Institutional first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $449K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • CX Institutional reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • CX Institutional sold 2,399 Allergan plc shares in Q2 2020, an estimated $425K.
  • CX Institutional first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • CX Institutional's Allergan plc position peaked at $449K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on CX Institutional's 13F filing for Q2 2020, filed 6 Aug 2020.